BD Medical - Pharmaceutical Systems manufactures and sells prefillable drug delivery systems to pharmaceutical and biotech companies.
Committed to drug delivery excellence. Our vision is to enable customer success with high quality and innovative drug delivery solutions that improve patient well-being.
Overview
With over 50 years of experience, we are empowering customer success through innovative drug-delivery solutions that improve patient quality of life.
>3Bn
Prefillable Syringes* (PFS) manufactured per year1
$2Bn
Yearly revenue (2022)**
7500
Associates globally
8
Manufacturing plants worldwide
Global headquarters
in Pont-de-Claix, France
Products used by more than 500 Pharmaceutical and Biotechnology companies.2
BD customers include 27 of the top 30 pharmaceutical companies in the world.3
~70% of the top 100 pharmaceutical companies around the world rely BD Medical-Pharmaceutical Systems prefillable drug-delivery systems for a wide variety of therapeutic applications.4
BD has generated over 4000 patents that are enforced in more than 25 countries.5
Patient Well-Being
There is a patient at the end of each of the billions of drug delivery devices that we make at BD. That is why we have invested in deep knowledge around patient experience, injection science and combination product development to anticipate customer challenges, manage complexities, and reduce risks. We also invest heavily to support our commitment to quality. Through our extensive global manufacturing network, we aim to offer security of supply and business continuity to our customers.
These, plus our ability to leverage the industry and health authority partnerships of a global healthcare company, are game changing advantages that BD brings to our customers’ drug delivery challenges.
We leverage these assets as we develop innovative solutions that provide peace of mind to customers and contribute to greater patient well-being.
Solutions to meet your needs across therapeutic areas
BD Medical - Pharmaceutical Systems manufactures and sells prefillable drug delivery systems to pharmaceutical and biotech companies.
BD uses proprietary needle technologies to develop needles that optimize your drug delivery.
BD offers a wide range of safety and shielding systems that feature innovative needle shielding system technology for your injectable drug
BD partners with you to develop self-injection systems that enable drug administration across a range of volumes and viscosities, leveraging BD primary container technologies and expertise with a focus on reaching the market faster.
To fulfill our system approach, we provide a complete set of components for your prefillable syringe systems.
Trusted Expertise
BD Effivax™ Glass Prefillable Syringe
BD SCF™ PremiumCoat® Plunger Stopper
BD Libertas™ Wearable Injector
BD Evolve™ On-body Injector
BD Neopak™ XtraFlow™ Glass Prefillable Syringe
ZebraSci combination product services
BD Hylok™ Glass Prefillable Syringe
BD Neopak™ XSi™ Glass Prefillable Syringe
BD Hypak™ for Vaccines Glass Prefillable Syringe
BD UltraSafe Plus™ 1mlL Passive Needle Guard
BD Sterifill Advance™ 50ml Polymer Prefillable Syringe
BD Neopak™ Glass Prefillable Syringe
BD acquires Safety Syringes Inc.
BD Vystra™ Disposable Pen
BD AutoShield Duo™ Safety Pen Needle
BD Physioject™ Disposable Autoinjector
BD Hypak™ for Biotech Glass Prefillable Syringe
BD Hypak Physiolis™ Glass Prefillable Syringe
BD Sterifill™ Polymer Prefillable Syringe
BD Eclipse™ Needle Shielding System
BD Accuspray™ Nasal Spray System
BD SCF™ FluroTec® Plunger Stoppers
5-bevel needle
BD Uniject™ Auto-Disable Prefillable Injection System
BD Sterifill™ Polymer Prefillable Syringe
BD SafetyGlide™ Needle Shielding System
Polypropylene corrugated materials
First SCF Filling process
BD Hypak™ Glass Disposable Syringe
BD Physioject™ - recognized by the Arthritis Foundation®
Best Production/Process Development
BD Intevia™ - Best Practices Award
Top 100 Global Innovator
BD Libertas™ wins prestigious Good Design® Award
Top 100 Global Innovators
Outstanding Corporate Innovator
World’s Most Admired Companies
Fill out our form to have one of our experts contact you.
Notes
* PFS containers
** BD Annual report 2022
References
BDM-PS Financial file November 2022, “Actual FY22” Permiter.
BDM-PS Financial file November 2020, "Actual FY20" Permiter.
BD Customers compared to Evaluate Pharma ranking FY2019
IQVIA: IQVIA dataset extracted on March 11th, 2021, from the IQVIA Smart MIDAS' on-line platform, includes WW sales of injectable drugs. Top 100 Corporation (based on IQVIA standard units 2020) selling PFS, Autoinjectors or Pens. TA included: Acute biologics, Anticoagulants, Chronic, Small molecules, Vaccines
BDM-PS Patents – In force – Worldwide – October 2021.
Solutions to meet your needs across therapeutic areas
BD Medical - Pharmaceutical Systems manufactures and sells prefillable drug delivery systems to pharmaceutical and biotech companies.
BD uses proprietary needle technologies to develop needles that optimize your drug delivery.
BD is uniquely positioned to offer prefillable syringe systems with expertise in drug container interactions, primary container selection and container/device integration for various drug therapies.
BD offers a wide range of safety and shielding systems that feature innovative needle shielding system technology for your injectable drug.
BD partners with you to develop self-injection systems that enable drug administration across a range of volumes and viscosities, leveraging BD primary container technologies and expertise with a focus on reaching the market faster.
To fulfill our system approach, we provide a complete set of components for your prefillable syringe systems.
Fill out our form to have one of our experts contact you.
Services and Solutions
BD understands the drug development process and objectives at each stage and offers a wide range of services to help develop container/device strategy and life cycle management plan for drugs.
BD Pharmaceutical Services and Solutions are designed to help you achieve your combination product goals, from development to launch.
BD PartnerPath™ Program aims to support pharmaceutical organizations that value speed to market in combination product development.1
Our Capabilities
We’ve built our services and capabilities around a deep understanding of the combination product development process and the key objectives at each stage, from discovery to delivery.
We are committed to partnering for your sustained commercial success.
Effective system integration can be critical to the success of combination products for pharmaceutical companies.1
We manufacture our solutions with a strict focus on continuously advancing quality, consistency and capacity.
Fill out our form to have one of our experts contact you.
References
Documentation
View research articles published in a journal and written by experts sharing study results that offer you insight into a particular topic.
View a scientific poster, such as those used for display at BD tradeshows or seminars to provide detailed information on a research topic
Learn more about order details, product specs, and technical information by viewing a brochure
Fill out our form to have one of our experts contact you.
Events
September 13 - 14, 2023
Conference on Wearable Injectors and Connected Devices
BD Effivax™ Glass Prefillable Syringe Features Enhanced Technology that Builds on Company’s Decades of Expertise in the Prefillable Syringe Market and Supports Customers’ Manufacturing Needs FRANKLIN LAKES, N.J. (September 13, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced a next-generation glass prefillable syringe (PFS) that sets a new standard in performance for vaccine PFS with new and tightened specifications for processability, cosmetics, contamination and integrity.1
Companies to work together with the aim of optimizing advanced technologies for use in prefillable syringes FRANKLIN LAKES, N.J. (May 18, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Mitsubishi Gas Chemical Company, Inc. (MGC), a R&D-oriented chemical manufacturer based in Tokyo, Japan, today announced that they have entered into an agreement to investigate further development of OXYCAPT™ - an innovation from MGC that integrates the best of plastic and glass for plastic syringes.
Fill out our form to have one of our experts contact you.
Contact Us
page load modal testing with multiple contact forms in page too